About Yaqrit
Yaqrit is a company based in London (United Kingdom) founded in 2014 by Rajiv Jalan. Yaqrit offers products and services including DIALIVE, CARBALIVE, and OPA Ammonia Scavenger. Yaqrit operates in a competitive market with competitors including Sequana Medical, Xlumena, Salient Surgical Technologies, Autem Therapeutics and Humedics, among others.
- Headquarter London, United Kingdom
- Founders Rajiv Jalan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Yaqrit Discovery Limited
- Date of Incorporation 25 Jan, 2019
- Jurisdiction HEREFORDSHIRE, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.01 M (USD), Grant
Mar 01, 2021
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yaqrit
Yaqrit offers a comprehensive portfolio of products and services, including DIALIVE, CARBALIVE, and OPA Ammonia Scavenger.
Liver support system for intensive care in liver failure patients.
Beads to restore gut microbiome and slow liver disease progression.
Treatment for hepatic encephalopathy in acute and chronic cases.
Funding Insights of Yaqrit
Investors in Yaqrit
Yaqrit has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Riveria Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Riveria Investment Group is engaged in private equity investments.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Yaqrit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yaqrit
Investment portfolio details for Yaqrit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yaqrit
Detailed financials for Yaqrit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yaqrit Comparisons
Peer comparison for Yaqrit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yaqrit
Yaqrit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Xlumena, Salient Surgical Technologies, Autem Therapeutics and Humedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Image-guided therapeutic endoscopy devices are developed for medical procedures.
|
|
| Locked | Locked | Locked |
Electrosurgical systems for surgical resections and procedures are developed.
|
|
| Locked | Locked | Locked |
Bioelectric platforms for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Liver function is assessed via point-of-care breath-based assays.
|
Detailed competitors of Yaqrit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yaqrit
Complete news archive for Yaqrit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yaqrit
Yaqrit was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Yaqrit is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Daniel Green is the current CEO of Yaqrit.
Yaqrit has developed devices for the treatment of liver diseases such as cirrhosis or liver failure. The company has developed a liver dialysis device, DIALIVE, to remove lipopolysaccharides and toxins from the blood. The company claimed that the clinical trials in patients would begin in 2018 and seek regulatory approval in 2019 or 2020.
Yaqrit's top competitors include Sequana Medical, CalmiGo and Salient Surgical Technologies.
Yaqrit offers DIALIVE, CARBALIVE, and OPA Ammonia Scavenger.
Yaqrit has 2 investors. Key investors include European Union, and Riveria Investment Group.